Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use
US8735604B2 · kind B2 · utility
1Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2010 |
| Grant date | May 27, 2014 |
| Priority date | — |
| Expiry date | Sep 16, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D207/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of the general formula: (I) wherein ring B, R1, R2, R3, Z, and L1 are selected independently of each other and are as defined herein, to compositions comprising the compounds, and methods of using the compounds as glucagon receptor antagonists and for the treatment or prevention of type 2 diabetes and conditions related thereto.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.